Friedmann-Morvinski et al.69 showed that inhibition of NFKBIE in human GBMs is strongly associated with reduced cell proliferation and impaired tumor progression, making NFKBIE an attractive therapeutic target for GBM. This evidence concerns the gene NFKBIE and glioblastoma.